Rutgers-led study NJ HEROES TOO focuses on the Black and Latinx communities disproportionately affected by COVID-19 in places where Rutgers academic medical centers are deeply rooted
A novel base editing technology invented at Rutgers, with the potential to be used for the creation of new cell and gene therapies, will be made available to researchers worldwide through an exclusive partnership with the Horizon Discovery Group.
Rutgers University was selected as one of five new hubs under the NIH’s Research Evaluation and Commercialization Hubs (REACH) program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators.
Rutgers University signs two agreements with Santhera Pharmaceuticals to advance pioneering research for the treatment of congenital muscular dystrophy. The agreements complement ongoing research of Peter Yurchenco, professor at Rutgers Robert Wood Johnson Medical School and a pioneer in a novel gene therapy approach for the treatment of LAMA2-deficient congenital muscular dystrophy.
Rutgers' Senior Vice President for Research and Economic Development issues statement in support of researchers participating in #ShutDownSTEM to actively support the ongoing Black Lives Matter movement and efforts against racism in the scientific community and society.
While many have been terrified by an invisible enemy, a group of drivers have known for sure that they are transporting and carrying the deadly coronavirus to the hands of Rutgers healthcare heroes with plastic face shields and white gowns.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.
HealthAdvance Fund™ announces its inaugural award to advance the commercialization of anti-cancer therapeutics being developed by researchers Raymond B. Birge from New Jersey Medical School and William Welsh from Robert Wood Johnson Medical School, in collaboration with Youyi Peng at the Rutgers Cancer Institute of New Jersey.
Amid the continuous need for COVID-19 test kits, Rutgers technologies once again prove invaluable to the fight against the pandemic that is sweeping the nation and the world. A recent COVID-19 rapid test that received FDA emergency use authorization includes molecular beacons technology, invented by Rutgers researchers.